Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | TACR1 | P25103 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.30 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2712747 | 0.92 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL2712748 | 0.92 | MEN1 (0.38) | ESR1MEN1KMT2AENPP1ACHE | |
| SCHEMBL12086118 | 0.91 | TDP1 (0.36) | ESR1ACHE | |
| SCHEMBL2712867 | 0.91 | TDP1 (0.36) | ESR1ACHE | |
| SCHEMBL2712696 | 0.90 | MEN1 (0.37) | MEN1KMT2A | |
| SCHEMBL2711812 | 0.89 | MEN1 (0.33) | MEN1KMT2ACYP11B2 | |
| SCHEMBL2711182 | 0.88 | TRPA1 (0.33) | MEN1KMT2ACYP11B2CYP1A2 | |
| SCHEMBL12086200 | 0.88 | TDP1 (0.38) | ESR1MEN1KMT2AENPP1ACHE | |
| SCHEMBL2709831 | 0.88 | TDP1 (0.38) | ESR1MEN1KMT2AENPP1ACHE | |
| SCHEMBL12086205 | 0.87 | CYP1A2 (0.40) | ESR1MEN1KMT2AENPP1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2445987-B1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | CYALUME TECH INC (US) | 2018-05-02 | — | — | EP | disclosed |
| EP-2445987-B1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | CYALUME TECH INC (US) | 2018-05-02 | — | — | EP | disclosed |
| US-8257620-B2 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| US-8257620-B2 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| EP-2445987-A1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | Cyalume Technologies, Inc (US) | 2012-05-02 | — | — | EP | disclosed |
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. | 2010-12-30 | — | — | US | disclosed |
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. | 2010-12-30 | — | — | US | disclosed |
| WO-2010151654-A1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | CYALUME TECHNOLOGIES, INC. (US) | 2010-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYP2F1, FLAD1, AFF1 | ESR1 979/4885MEN1 1898/4885KMT2A 3905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.